Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Phase 2 Interventional

Paclitaxel in Treating Patients With Ovarian Epithelial Cancer or Primary Peritoneal Cancer

ClinicalTrials.gov ID: NCT00023907

Public ClinicalTrials.gov record NCT00023907. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Nov 3, 2026, 1:49 PM EST

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase II Evaluation of Weekly Paclitaxel in the Treatment of Recurrent or Persistent Platinum and Paclitaxel-Resistant Ovarian or Primary Peritoneal Cancer

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. PURPOSE: Phase II trial to study the effectiveness of paclitaxel in treating patients who have recurrent or persistent ovarian epithelial cancer or primary peritoneal cancer.

Study identification

NCT ID
NCT00023907
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 2
Lead sponsor
Gynecologic Oncology Group
Network
Enrollment
Not listed

Conditions and interventions

Eligibility (public fields only)

Age range
Not listed
Sex
Female
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jul 2001 (Type not available)
Primary completion
Apr 2006 (Actual)
Completion
Not listed
Last update posted
Apr 11, 2013

Started 2001

United States locations

U.S. sites
44
U.S. states
22
U.S. cities
41
Facility City State ZIP Site status
CCOP - Western Regional, Arizona Phoenix Arizona 85006-2726 —
Women's Cancer Center at Community Hospital of Los Gatos Los Gatos California 95032 —
Chao Family Comprehensive Cancer Center at University of California Irvine Cancer Center Orange California 92868 —
CCOP - Christiana Care Health Services Newark Delaware 19713 —
MBCCOP - Hawaii Honolulu Hawaii 96813 —
Rush-Presbyterian-St. Luke's Medical Center Chicago Illinois 60612-3824 —
MBCCOP - University of Illinois at Chicago Chicago Illinois 60612 —
CCOP - Evanston Evanston Illinois 60201 —
Memorial Medical Center Springfield Illinois 62794-9640 —
CCOP - Carle Cancer Center Urbana Illinois 61801 —
Indiana University Cancer Center Indianapolis Indiana 46202-5289 —
Saint Joseph Regional Medical Center South Bend Indiana 46617 —
Holden Comprehensive Cancer Center at University of Iowa Iowa City Iowa 52242-1002 —
Markey Cancer Center at University of Kentucky Chandler Medical Center Lexington Kentucky 40536-0084 —
Warren Grant Magnuson Clinical Center - NCI Clinical Studies Support Bethesda Maryland 20892-1182 —
CCOP - Michigan Cancer Research Consortium Ann Arbor Michigan 48106 —
CCOP - Grand Rapids Grand Rapids Michigan 49503 —
CCOP - Kalamazoo Kalamazoo Michigan 49007-3731 —
CCOP - Metro-Minnesota Saint Louis Park Minnesota 55416 —
Keesler Medical Center - Keesler Air Force Base Keesler Air Force Base Mississippi 39534-2576 —
Ellis Fischel Cancer Center at University of Missouri - Columbia Columbia Missouri 65203 —
CCOP - Kansas City Kansas City Missouri 64131 —
CCOP - Cancer Research for the Ozarks Springfield Missouri 65807 —
CCOP - Missouri Valley Cancer Consortium Omaha Nebraska 68106 —
Roswell Park Cancer Institute Buffalo New York 14263-0001 —
Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill Chapel Hill North Carolina 27599-7295 —
Duke Comprehensive Cancer Center Durham North Carolina 27710 —
Comprehensive Cancer Center at Wake Forest University Winston-Salem North Carolina 27157-1065 —
Charles M. Barrett Cancer Center at University Hospital Cincinnati Ohio 45267-0526 —
Ireland Cancer Center Cleveland Ohio 44106 —
Cleveland Clinic Taussig Cancer Center Cleveland Ohio 44195 —
Arthur G. James Cancer Hospital - Ohio State University Columbus Ohio 43210-1240 —
CCOP - Columbia River Oncology Program Portland Oregon 97225 —
Abington Memorial Hospital Abington Pennsylvania 19001-3788 —
CCOP - Geisinger Clinic and Medical Center Danville Pennsylvania 17822-2001 —
Penn State Cancer Institute at Milton S. Hershey Medical Center Hershey Pennsylvania 17033-0850 —
Fox Chase Cancer Center Philadelphia Pennsylvania 19111 —
Magee-Womens Hospital Pittsburgh Pennsylvania 15213-3180 —
Southeast Gynecologic Oncology Associates Knoxville Tennessee 37917 —
Genecologic Oncology Network Nashville Tennessee 37203 —
Vanderbilt-Ingram Cancer Center at Vanderbilt Medical Center Nashville Tennessee 37232-2516 —
University of Texas Medical Branch Galveston Texas 77555-0587 —
CCOP - Scott and White Hospital Temple Texas 76508 —
CCOP - Marshfield Clinic Research Foundation Marshfield Wisconsin 54449 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00023907, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 11, 2013 · Synced Nov 3, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00023907 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →